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Abstract
Preferential localization of liposomes at sites of infection or inflammation has been demonstrated in a variety of
experimental models. Most studies report enhanced localization at the target site of poly(ethyelene) glycol (PEG)-coated
liposomes as compared to conventional non-coated liposomes. It is generally accepted that the prolonged circulation time of
PEG-coated liposomes increases target site exposure, which results in increased target localization. A quantitative
relationship between circulation kinetics and localization at the pathological site has not been defined as yet. Besides, an
effect of the PEG coating itself has been suggested, as theoretically the PEG coating may facilitate liposome extravasation. In
the present study, in a rat model of an acute unilateral Klebsiella pneumoniae pneumonia, circulation kinetics of PEG-coated
liposomes were manipulated by incorporation of different amounts of phosphatidylserine (PS) and variation of lipid dose,
additionally allowing evaluation of the saturability of the localization process. In addition, this paper addresses the effect of
the PEG coating, by comparing the circulation kinetics and target localization of long-circulating ‘PEG-free’ and PEG-
coated liposomes. It is shown that the degree of liposome localization at the target site is positively linearly related to the area
under the blood concentration time curve (AUC) of the liposome formulations, irrespective of PEG coating. This finding is
discussed in relation to the equation of Kedem and Katchalsky, which describes protein influx into sites of infection or
inflammation. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
In a variety of experimental models of infection or
in£ammation, liposomes have been demonstrated to
localize at the pathological site [1^7]. The localiza-
tion is dependent on the in£ammatory response as
the localization at comparable anatomical sites in
uninfected control animals is generally insigni¢cant.
As a result, liposomes have attracted considerable
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interest as targeted drug carriers for application in
infection and in£ammation. In order to maximize the
degree of liposome localization at the target site, it is
essential to identify which factors contribute to the
passive targeting of liposomes to in£amed sites.
With respect to the in£amed target site, this area is
characterized by an increased blood £ow, and an
increased capillary permeability causing edema. The
£uid £ux into the target site facilitates movement of
the phagocytes and promotes plasma protein local-
ization supporting the host defense. The in£ux of
plasma proteins into the in£amed site has been math-
ematically described by Kedem and Katchalsky [8]
as:
Js  Jv 13c  Cs  Pc Sc vC 1
where Js and Jv are the £uxes of the studied protein
and of £uid, respectively, c is the re£ection coe⁄-
cient (fraction of the protein that is stopped by the
microvascular barrier), Cs is the average protein con-
centration in the capillary, Pc Sc is the capillary per-
meability- capillary surface area product, and vC is
the protein concentration di¡erence across the endo-
thelium. The ¢rst term of the equation describes the
convective transport component (Jv (1-c) Cs), where-
as the second term describes the di¡usion component
(Pc Sc vC). Assuming that liposome £ux into the
target site can also be described by this equation,
two liposome-related factors would then determine
the degree of liposome localization: the ability of
the liposomes to cross the vascular endothelium (de-
termined by c) and the liposome concentration in the
blood (Cs). The Pc Sc vC component of the equation
is negligible due to the low di¡usion coe⁄cient of
particulate systems. The £uid £ux (Jv) is not related
to the particulate system but to the in£ammatory
response. Therefore, only Cs and c seem to be the
main determining parameters in the liposome local-
ization process.
Several studies have shown an improved target site
localization of liposomes coated with poly(ethylene)
glycol (PEG), also known as sterically stabilized lipo-
somes (SSL), compared to conventional liposomes
lacking the PEG coating [1^6]. It is generally ac-
cepted that the higher degree of localization is en-
abled by the prolonged circulation time of SSL.
The increased average liposome concentration in
the capillaries at the in£amed area, yields increased
exposure of the target site to the liposomes, suggest-
ing that the liposome concentration (or Cs) in time is
important for target localization. Besides, permeabil-
ity studies in tumor tissue suggest that the PEG coat-
ing itself can promote target localization [9]. A less
interactive liposome surface, conferred by the PEG
coating, which could also be interpreted as a reduced
re£ection coe⁄cient (or c), may facilitate their ex-
travasation at sites of increased capillary permeabil-
ity.
Up to now, a limited number of qualitative studies
has appeared on the relationship between circulation
kinetics (i.e. involvement of the Cs parameter) and
degree of localization of SSL in the pathological tar-
get tissue, as has been discussed by Storm and
Woodle [10]. In the present study, this relationship
is explored in more detail. In a rat model of an acute
unilateral Klebsiella pneumoniae pneumonia in rats,
SSL circulation kinetics were manipulated by incor-
poration of di¡erent amounts of phosphatidylserine
(PS) [11,12]. Circulation kinetics were also manipu-
lated by variation of lipid dose, additionally allowing
evaluation of the saturability of the localization pro-
cess. A relationship between liposomal circulation
time and target site localization was established on
the basis of the collected data. In addition, this paper
addresses the e¡ect of the PEG coating itself (i.e.
involvement of the c parameter) by comparing the
circulation kinetics and target localization of long-
circulating ‘PEG-free’ liposomes and SSL.
2. Materials and methods
2.1. Liposome preparation and characterization
Liposomes were prepared as described previously
[2] using appropriate amounts of the following lip-
ids: partially hydrogenated egg phosphatidyl choline
(PHEPC) (Asahi, Ibarakiken, Japan), cholesterol
(Chol), L-K-phosphatidyl-L-serine (PS) (Sigma, St.
Louis, MO), 1,2-distearoyl-sn-glycero-3-phospho-
ethanolamine-N-[polyethylene glycol-2000] (PEG-
DSPE), or distearoyl phosphatidyl choline (DSPC)
(Avanti Polar Lipids, Alabaster, Alabama). In brief,
lipids were dissolved in a mixture of chloroform and
methanol. The solvent was evaporated and the lipids
were dried, redissolved in 2-methyl-2-propanol (Sig-
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ma, St. Louis, MO), frozen, and freeze-dried over-
night. The resulting lipid ¢lm was hydrated in
HEPES/NaCl bu¡er, pH 7.4 (10 mM N-[2-hydroxy
ethyl]piperazine-NP-ethane sulfonic acid (HEPES)
(Sigma, St. Louis, MO), 135 mM NaCl (Merck,
Darmstadt, Germany), and 5 mM of the chelator
deferoxamine mesylate (Desferal) (Novartis, Basle,
Switzerland).
The liposome dispersion was sonicated for 8 min
with an amplitude of 8 Wm using a 9.5-mm probe in
an MSE Soniprep 150 (Sanyo Gallenkamp PLC, Lei-
cester, UK) to obtain liposomes with a mean particle
size of 100 nm. Dynamic light scattering, detected at
an angle of 90‡ to the laser beam on a Malvern 4700
System (Malvern Instruments, Malvern, UK), was
measured to evaluate the particle size distribution.
In addition to the mean particle size, the system re-
ports a polydispersity index (a value between 0 and
1). A polydispersity index of 1 indicates large varia-
tions in particle size, a reported value of 0 means
that size variation is absent. All liposome prepara-
tions used had a polydispersity index below 0.3. The
DSPC:Chol preparation with a mean size of 80 nm
was obtained by multiple extrusion at 60‡C of the
liposome dispersion through two stacked polycar-
bonate membranes (Nuclepore, Pleasanton, CA)
with a ¢nal pore size of 50 nm. Mean particle size
was 80 nm.
2.2. Radiolabeling of liposomes
Liposomes were radiolabeled with 67Ga, as de-
scribed previously [2]. In brief, non-encapsulated de-
feroxamine was removed by gel ¢ltration. Liposomes
were concentrated via ultracentrifugation. 67Ga-cit-
rate (1 mCi/ml) (Mallinckrodt Medical, Petten, The
Netherlands) was diluted 1:10 in aqueous 5 mg/ml 8-
hydroxyquinone (Sigma, St. Louis, Missouri) and in-
cubated for 1 h at 52‡C to yield 67Ga-oxine. One
milliliter of this solution was added per 1000 Wmol
total lipid (TL). 67Ga-oxine can pass the liposomal
membrane and form a complex with the entrapped
chelator deferoxamine. The complex is an appropri-
ate label for monitoring intact liposomes in the cir-
culation as it is rapidly renally excreted once it is
released from circulating liposomes [13]. Free label
was removed by gel ¢ltration and labeled liposomes
were concentrated by ultracentrifugation. Resulting
speci¢c activities were between 1U104 and 2U105
cpm/Wmol TL. Phosphate concentration was deter-
mined spectrophotometrically according to Bartlett
[14].
2.3. Unilateral pneumonia
The animal experiments ethical committee of the
Erasmus University Medical Center Rotterdam ap-
proved the experiments described in this study. Fe-
male albino RP/AEur/RijHsd strain albino rats, 18^
25 weeks of age, body weight 185^225 g (Harlan,
Horst, The Netherlands) with a speci¢ed pathogen-
free status were used. A left-sided unilateral pneumo-
nia was induced as described previously [15]. In brief,
rats were anesthetized and the left primary bronchus
was intubated. Through the tube, 0.02 ml of a saline
suspension containing 106 K. pneumoniae (ATCC
43816, capsular serotype 2) was inoculated in the
left lung lobe. Rats were housed individually with
free access to water and SRMA chow (Hope Farms,
Woerden, The Netherlands).
2.4. Blood clearance and biodistribution
Experimental groups consisted of six rats. At the
indicated time points after bacterial inoculation of
the left lung, liposomes were injected at the indicated
dose in the tail vein. At indicated time points after
injection, blood samples of approximately 0.3 ml
were taken, by retro-orbital puncture, from alternate
groups of three rats. After measuring sample volume,
radioactivity was counted in a Minaxi autogamma
5000 gamma counter (Packard Instrument, Meriden,
CT). To determine the tissue distribution of the lipo-
somes, rats were sacri¢ced by CO2 inhalation. Sub-
sequently, organs were dissected, weighed and radio-
activity was counted. Organ radioactivity was
corrected for radioactivity present in the blood (see
below).
2.5. Total blood volume and blood content of tissues
Total blood volume of infected rats was deter-
mined, in an independent experiment, as being
5.3% of the total body weight. Syngeneic erythro-
cytes labeled with 111In-oxine according to Kurant-
sin^Mills were used [16]. Blood samples were taken
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at 10 min after injection of the labeled erythrocytes
assuming that all erythrocytes were still present in
the circulation. The dilution factor of the radioactive
label allowed calculation of the total blood volume.
Sample volume and blood volume allowed calcula-
tion of total blood radioactivity content. This tech-
nique was also used to determine blood content of
the tissues at appropriate time points after inocula-
tion.
2.6. Statistical analysis
SSL display single ¢rst-order clearance rates, inde-
pendent of dose [17,18]. Similarly, in our study,
blood clearance pro¢les of individual animals could
be well described by a linear relationship on a semi-
logarithmic plot (0.886 r6 1.00), which allowed es-
timation of individual area under the blood concen-
tration^time curve (AUC) values.
Liposome localization data were tested for homo-
geneity of variance using Levene’s statistic. Data
were log transformed in case of signi¢cant di¡eren-
ces. Infected left lung and right lung localization was
compared using the paired t-test. Comparisons be-
tween groups were made by one-way analysis of var-
iance (ANOVA). The Bonferroni method was used
to correct for multiple comparisons. All analyses
were performed using SPSS for Windows software
release 7.5.2 (Statistical Product and Service Solu-
tions, Chicago, USA).
3. Results
3.1. Manipulation of AUC by incorporation of PS and
e¡ect on degree of infected left lung localization
of SSL
Incorporation of PS was used to manipulate the
circulation time of SSL, as PS is a strong recognition
signal for macrophage uptake, which cannot be pre-
vented by the presence of PEG-DSPE at the usually
applied amount of 5 mol% [11,12]. The circulation
kinetics and biodistribution pro¢les of SSL contain-
ing either 0, 1, or 10 mol% PS in the bilayer are
shown in Fig. 1A,B, respectively. The AUC0ÿ24h of
the 1 and 10 mol% PS-SSL was 2.0-fold and 2.6-fold
lower, respectively, compared to that of the 0 mol%
PS-SSL. Regarding the biodistribution pro¢le at 24 h
after injection, the three liposome preparations dis-
played an approximately 4-fold higher localization in
the infected left lung compared to the uninfected
right lung (P6 0.001, Fig. 1B). The degree of local-
ization in the infected lung was 2.5-fold higher for
the 0 mol% PS containing SSL compared to the 1 and
10 mol% PS containing SSL (P6 0.001). The di¡er-
Fig. 1. E¡ect of incorporation of 0, 1, or 10 mol% PS on blood
clearance and degree of localization of SSL in infected left lung
and right lung tissue. 67Ga-labeled liposomes were injected i.v.
at 40 h after bacterial inoculation of the left lung at a dose of
75 Wmol TL/kg. Lipid composition was PHEPC:Chol:PEG-
DSPE:PS 1.85:1.00:0.15:0 mol:mol for the 0 mol% PS contain-
ing liposomes, 1.82:1.00:0.15:0.03 for the 1 mol% PS prepara-
tion, and 1.55:1.00:0.15:0.30 for the 10 mol% PS preparation.
(A) nmol TL/ml blood was calculated from radioactivity recov-
ered (n = 3, Mean þ S.D.). (B) nmol TL/lung at 24 h after injec-
tion was calculated from radioactivity recovered (n = 6,
mean þ S.D.). *P6 0.05, **P6 0.01, ***P6 0.001. Signi¢cant
di¡erences versus the 0 mol% PS preparation are indicated.
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ences in localization in the right lung between the
various SSL types showed a similar pattern
(P6 0.05 and P6 0.001, respectively).
3.2. Manipulation of AUC by variation of lipid dose
and e¡ect on degree of infected left lung
localization of SSL
SSL were injected i.v. at lipid doses from 25 up to
375 Wmol TL/kg. The resulting values for AUC0ÿ24h
and corresponding infected left lung localization at
24 h after injection are presented in Fig. 2A,B, re-
spectively. The AUC0ÿ24h value as well as degree of
left lung localization increased linearly with escalat-
ing dose. For all doses tested, the localization in the
infected lung was approximately 3-fold higher than
the localization in the right lung (data not shown,
P6 0.001).
3.3. E¡ect of PEG coating on degree of infected left
lung localization of liposomes
To assess whether the presence of a PEG coating
has a facilitating e¡ect on target site extravasation,
two liposome types were studied: (1) long-circulating
small rigid liposomes (LCL) without a PEG coating
(DSPC:Chol, 2:1, mol:mol); and (2) SSL (PEG-
DSPE:PHEPC:Chol 0.15:1.85:1.0 mol:mol). The
Fig. 2. E¡ect of lipid dose on AUC0ÿ24h (A) and degree of left
lung localization (B) of 67Ga-labeled SSL. Lipid composition
was PHEPC:Chol:PEG-DSPE 1.85:1.00:0.15 mol:mol. See the
legend of Fig. 1 for experimental conditions.
Fig. 3. Blood clearance (A) and degree of localization (B) in in-
fected left lung and right lung tissue of 67Ga-labeled SSL (lipid
composition PHEPC:Chol:PEG-DSPE 1.85:1.00:0.15 mol:mol)
and PEG-free small rigid long-circulating liposomes (LCL) (lip-
id composition DSPC:Chol 2:1 mol:mol). See the legend of
Fig. 1 for experimental conditions.
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circulation kinetics and biodistribution pro¢les are
shown in Fig. 3A,B, respectively. The slow clearance
pro¢les of the long-circulating PEG-free liposomes
and the SSL were similar, as is re£ected by approx-
imately equal AUC0ÿ24h values. In line with these
results, the degree of localization in the infected left
lung was similar for both long-circulating liposome
types. Both formulations demonstrated an approxi-
mately 3-fold higher degree of localization in the in-
fected left lung compared to the degree of localiza-
tion in the uninfected right lung (P6 0.001, Fig. 3B).
3.4. Correlation between AUC0ÿ24h and degree of
infected left lung localization of liposomes
Collected data regarding AUC0ÿ24h-values and re-
garding degree of infected lung localization in indi-
vidual animals taken from Figs. 1^3, are presented in
Fig. 4. A positive linear correlation was obtained
(r = 0.92, P6 0.001).
3.5. Relationship between infected left lung weight,
AUC, and degree of infected left lung localization
of SSL versus time after bacterial inoculation
An implication of liposome concentration as a
driving force for target localization would be that
the driving force gradually weakens in time as a re-
sult of reduced blood levels due to liposome clear-
ance. Therefore, left lung weight (as a measure of
£uid in£ux), liposomal AUC, and degree of infected
left lung localization of SSL was determined at di¡er-
Fig. 4. Relationship between AUC0ÿ24h values and correspond-
ing degree of left lung localization of individual animals for in-
dicated liposome formulations.
Fig. 5. Infected left lung weight (A), AUC value of SSL (B), and degree of infected left lung localization of SSL (C) at di¡erent time
points after liposome injection. 67Ga-labeled liposomes were injected i.v. at 24 h after bacterial inoculation of the left lung at a dose
of 75 Wmol TL/kg. Rats were dissected at the indicated time points and left lung weight, degree of SSL left lung localization, and SSL
blood concentration were determined. The AUC values were calculated from individual blood clearance kinetics. n = 3^6 animals per
time point. Mean þ S.D.
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ent time points after liposome injection (Fig. 5A^C).
To obtain a clear e¡ect of liposome clearance from
the bloodstream, of these long-circulating SSL, data
had to be collected over a 48-h period. To be able to
collect data over this time period, liposomes were
injected at 24 h after bacterial inoculation as some
animals died shortly after 72 h after inoculation. Fig.
5A shows that the increase in left lung weight is
linear in time (r = 0.92, P6 0.001). Both liposomal
AUC and degree of liposome left lung localization
show a hyperbolic curve (Fig. 5B,C, respectively).
Over 70% of the liposome AUC and degree of left
lung localization is achieved in the ¢rst 24 h.
4. Discussion
Similar to plasma proteins, long-circulating SSL
have been shown to localize preferentially at sites
of infection or in£ammation [1^7]. The equation of
Kedem and Katchalsky (see Section 1) has been used
to describe the in£ux of proteins into in£amed areas
[8]. If the same equation also applies to liposome
in£ux into in£ammatory foci, then target localization
would be dependent on the ability of liposomes to
cross the vascular endothelium, determined by the
re£ection coe⁄cient (c), and liposome concentration
in the bloodstream (Cs). SSL with prolonged circu-
lation times generally show a higher degree of target
site localization compared to non-coated liposomes
with shorter circulation times, which points to the
involvement of Cs [1^6]. In addition, the PEG coat-
ing of SSL may have a promoting e¡ect on target site
localization itself by conferring a less interactive sur-
face to the liposome, which implies a reduction of c
[9]. At present, a systematic investigation of the e¡ect
of circulation time and PEG coating on the degree of
liposome localization at in£amed areas is lacking.
The approach taken in the present study to investi-
gate the e¡ect of circulation kinetics of SSL on target
localization was to incorporate PS in SSL and to
vary SSL dose. The e¡ect of PEG coating was
studied by comparing circulation kinetics and degree
of target site localization values of long-circulating
liposomes without PEG coating to those of SSL.
The rate of SSL removal from the blood increased
with an increasing amount of PS in the liposomal
bilayers. A similar PS e¡ect has been observed by
Boerman et al. [11]. Increased clearance from the
circulation was paralleled by a diminished target
site accumulation. The incorporation of PS could
have an intrinsic e¡ect on SSL biodistribution as a
result of increased negative surface charge or induc-
tion of defects in the PEG coating. More likely, the
reduced circulation time of PS-containing SSL re-
duces the number of liposomes able to interact
with the target site over time (reduction in Cs), lead-
ing to a diminished target site localization. The re-
sults reveal that the reduction in AUC is directly
proportional to the reduction in degree of target lo-
calization.
Liposomal AUC was also manipulated by varia-
tion of the lipid dose. The rise in AUC values was
proportional to the increase in administered lipid
dose, showing that the pharmacokinetics of SSL
are independent of dose between 25 and 375 Wmol
TL/kg. Dose-independent pharmacokinetics of SSL
over this dose range have also been observed earlier
in healthy animals by Allen and Hansen [18]. Here
we show that the degree of target site localization
increases proportionally to the administered dose,
which points out that saturation of target localiza-
tion does not occur within the dose range of 25^375
Wmol TL/kg and further supports the notion that the
liposome concentration (or Cs) ‘drives’ the localiza-
tion in the infected left lung.
It has been argued that the presence of a PEG
coating facilitates liposome extravasation at sites of
increased capillary permeability, which could be in-
terpreted as a reduction of the re£ection coe⁄cient
(c). This issue was addressed by comparing the cir-
culation kinetics and target site localization of long-
circulating liposomes without PEG coating to SSL.
Since the long-circulating liposome formulation lack-
ing the PEG coating shows similar AUC and target
site localization values as the SSL formulation, it
appears that the presence of a PEG coating does
not contribute signi¢cantly to the degree of liposome
localization at the site of infection and that the value
for c is equal for both liposome types. Thus, the
long-circulating property is the decisive parameter
in this respect. Experiments, similar to those de-
scribed by Waypa et al. [19], to measure the actual
value of c for liposomes in in£ammatory conditions
could yield important information to maximize the
degree of liposome target localization.
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The linear relationship obtained by plotting the
AUC values of the liposome formulations tested
and corresponding target site localization values in
individual animals emphasizes that liposome concen-
tration is the prime determinant of liposome extra-
vasation at the target site and supports the usefulness
of the Kedem and Katchalsky equation for describ-
ing liposome in£ux at the the site of infection.
Liposome concentration as a driving force for tar-
get localization implies that the liposome in£ux at
the target site gradually slows down as a result of
liposome clearance. Experimental support for this
notion was obtained by determining lung weight,
and degree of left lung localization of SSL at di¡er-
ent time points after injection and calculation of the
AUC values between liposome injection and tissue
dissection. It is shown that the lung weight increase
is linear in time, which indicates that £uid in£ux into
the site of infection (Jv) occurs at an approximately
constant rate (r = 0.92, P6 0.001). Both cumulative
AUC and liposome localization show a hyperbolic
curve, indicating that a gradual decrease in liposomal
blood concentration results in a proportional de-
crease in target localization, which again con¢rms
that AUC is the main factor driving the passive tar-
geting e¡ect.
A theoretical implication of the Kedem and Kata-
chalsky is that, during £uid £ux into the site of in-
fection (Jvs 0) and a liposomal re£ection coe⁄cient
that allows passage through the vascular endothe-
lium (c6 1), target localization of long-circulating
liposomes will occur and will not be saturable.
Therefore, the design of liposomes with a longer cir-
culation time compared to that of the liposome for-
mulations used in the present study can be expected
to provide for a higher degree of target localization,
indicating that there is still room for improvement.
Our results deviate from those of Longman and co-
workers who investigated the localization of i.v. ad-
ministered liposomes with various circulation times
in peritoneal £uid [20]. Localization of SSL in peri-
toneal £uid was not increased compared to conven-
tional liposomes, despite signi¢cant di¡erences in cir-
culation times. Limited £uid transport (Jv) due to an
intact microvascular barrier in the abdomen (possess-
ing a high re£ection coe⁄cient (c)) likely explains
these results.
In conclusion, the present study clearly shows for
the ¢rst time that the blood concentration is the pri-
mary factor driving localization of liposomes into the
K. pneumoniae-infected target site. In addition, the
PEG coating itself does not contribute signi¢cantly
to the degree of liposome target localization. The
design of liposomes with longer circulation times as
compared to those of the SSL used in this study can
be predicted to result in a higher degree of target
localization of liposomes.
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